Bioeconomy - present status and future needs of industrial value chains.

The necessary reduction of greenhouse gas emissions requires a comprehensive shift from fossil to renewable raw materials. This is accompanied by a fundamental reorganization of the value chains of the energy sectors and large parts of the manufacturing industry. In the long term, bio-based industrial raw materials will be processed preferentially by the chemical industry.

How to capture the bioeconomy's industrial and regional potential through professional cluster management.

The bioeconomy transforms the fossil-based economy by forming new value chains and linking until now distinct industrial sectors. It provides an opportunity for rural as well as industrialized regions. The transformation process can be accelerated by building bioeconomy clusters comprising industries, academia and investors.

Sustainability of biofuels and renewable chemicals production from biomass.

In the sectors of biofuel and renewable chemicals the big feedstock demand asks, first, to expand the spectrum of carbon sources beyond primary biomass, second, to establish circular processing chains and, third, to prioritize product sectors exclusively depending on carbon: chemicals and heavy-duty fuels. Large-volume production lines will reduce greenhouse gas (GHG) emission significantly but also low-volume chemicals are indispensable in building 'low-carbon' industries. The foreseeable feedstock change initiates innovation, securing societal wealth in the industrialized world and creating employment in regions producing biomass.

Ask the experts: the challenges and benefits of flow chemistry to optimize drug development.

Against a backdrop of a struggling economic and regulatory climate, pharmaceutical companies have recently been forced to develop new ways to provide more efficient technology to meet the demands of a competitive drug industry. This issue, coupled with an increase in patent legislation and a rising generics market, makes these themes common issues in the growth of drug development. As a consequence, the importance of process chemistry and scale-up has never been more under the spotlight.

How to turn industrial biotechnology into reality.

The emerging bioeconomy is pulled by consumers asking for sustainable products and processes, governments enforcing climate protection and industries demanding feedstock flexibility and last but not least it is pushed by progress in basic and applied science. It will use renewable carbon sources not only from agri- and silviculture, but potentially also from industrial flue gases - for example, from power generation and steel production. Connecting such industries with the future bio-chemical industry results in a challenging new value chain which connects thus far separated industries.

White biotechnology: ready to partner and invest in.

It needs three factors to build an industry: market demand, product vision and capital. White biotechnology already produces high volume products such as feed additive amino acids and specialty products like enzymes for enantioselective biocatalysis. It serves large and diverse markets in the nutrition, wellness, pharmaceutical, agricultural and chemical industry.